Dendritic cells (DCs) 
Summary
Dendritic cells (DCs) genes, which are involved in retinoic acid metabolism and transforming growth factor-b (TGF-b) activation, respectively. Exogenous TGF-b supplementation equalized the level of Foxp3 + T-cell induction by the four subsets whereas retinoic acid did not, which suggests that high ability to activate TGF-b is determinant for the high Foxp3 + T-cell induction by CD11b À CD103 + PD-L1 High DC subset. Finally, this subset exhibited a
Introduction
The intestinal immune system should be precisely regulated to prevent destructive immune responses toward antigens derived from beneficial or non-harmful substances and organisms, such as foods and commensal bacteria. Otherwise, excessive immune responses could lead to, for example, food allergy and inflammatory diseases. The intestinal immune system is set to suppress immune responses to orally administered antigens in the steady state. Further, oral administration of an antigen can suppress immune responses to subsequent systemic challenge of the antigen, referred to as oral tolerance.
are classified into two types based on their origins, i.e. thymus-derived Treg (tTreg) cells and peripherally derived Treg (pTreg) cells. 10 Among them, pTreg cells play a pivotal role in inducing oral tolerance. 11 Indeed, a large proportion of the pTreg cells in the small intestine are dependent on food-derived antigens. 12 Oral tolerance is induced mainly in mesenteric lymph nodes (MLNs), considering surgical removal of MLNs in mice abrogates induction of oral tolerance. 13 Hence, the MLN is probably a main site for the induction of pTreg cells specific to orally administered antigens, which are required for oral tolerance. Further, these pTreg cells should migrate to the intestine to induce oral tolerance. 14, 15 T-cell homing to the small intestine is mediated by CCR9 and integrin a 4 b 7 . 16, 17 In the intestine, CD103
+ dendritic cells (DCs) play a crucial role in tolerogenic responses including Treg cell induction. 18 Many studies have revealed that MLN 19-21 MLN CD103 + DCs highly express RALDH2 enzyme, which metabolizes retinal to RA. 19, 22, 23 In addition to Treg cell induction, RA also induces guthoming receptors, CCR9 and integrin a 4 b 7 , on T cells. 24 Hence, CD103 + DCs, which highly express RALDH2, can induce gut-homing Treg cells. 19, 25 MLN CD103 + DCs also highly express TGF-b. 19 The TGF-b is secreted as a latent form and needs to be cleaved into the active form. The intestinal CD103
+ DCs further mediate this activation process through integrin a v b 8 . [26] [27] [28] [29] Besides, the intestinal CD103 + DCs induce Treg cells and subsequent oral tolerance through indoleamine 2,3-dioxygenase (IDO) activity, which mediates tryptophan catabolism. 30 To induce Treg cells specific to orally administered antigens in MLNs, DCs should obtain the antigens in the intestine and then migrate to MLNs. CD103 + DCs capture luminal antigens directly by extending their dendrites to the lumen and indirectly through goblet cells. 31, 32 In addition, they can receive the antigens from CD103 À CX 3 CR1 + macrophages, which can take up antigens directly from the lumen, in the intestinal lamina propria. 33, 34 Lamina propria CD103 + DCs can migrate to MLNs in a CCR7-dependent manner. [35] [36] [37] Hence, CD103 + DCs capture luminal antigens, migrate to MLNs, and present the antigens to T cells, which results in induction of Treg cells specific to orally administered antigens.
Besides the many studies on CD103 + DCs mentioned above, another study has reported that programmed death ligand 1 (PD-L1) and PD-L2, co-stimulatory molecules expressed on DCs, are important for Treg cell induction by MLN DCs. 38 
Materials and methods

Mice
BALB/c mice (CLEA Japan, Tokyo, Japan) and DO11.10 mice 39 were used at 7-20 weeks old. In some experiments, BALB/c mice were fed water containing ovalbumin (OVA; Wako, Osaka, Japan) (200 mg/ml) ad libitum for 3 days before cell isolation. All experiments were approved by the Animal Use Committee of the Faculty of Agriculture at the University of Tokyo and were performed in accordance with The University of Tokyo guidelines for animal care and use.
Media and reagents
RPMI media and 10% fetal calf serum (FCS)-RPMI media were prepared as described previously. 40 For flow cytometry, anti-a 4 b 7 -allophycocyanin (APC) (DATK32),
, streptavidin-Peridinin chlorophyll protein, streptavidin-PE/Cy7, and streptavidin-APC were purchased from BioLegend (San Diego, CA); anti-CD103-FITC (2E7), anti-Foxp3-PE (FJK-16s), anti-PD-L2 (TY25), and anti-PD-L2-biotin (TY25) were purchased from eBioscience (San Diego, CA); anti-CD8a-PE/Cy7 (53-6.7) and anti-CD11b-APC (M1/70) were purchased from TONBO biosciences (San Diego, CA); anti-I-A/I-E-PE (M5/114.15.2) and streptavidin-PE/Cy5 were purchased from BD Bioscience (San Jose, CA). OVA323-339 peptide (OVAp; ISQAVHAAHAEINEAGR) was purchased from Operon Biotechnologies (Tokyo, Japan). DMSO was purchased from Sigma (St Louis, MO). LE540 (Wako) and all-trans-RA (Wako) were stored at 10 mM in DMSO, and human TGF-b 1 (hTGF-b; R&D Systems, Minneapolis, MN) was stored at 4 lg/ml in PBS. These stocks were diluted by media for use. 5(6)-Carboxyfluorescein N-hydroxysuccinimidyl ester (CFSE) was purchased from Molecular Probes (Eugene, OR).
Cell isolation
The MLNs were removed and incubated in 10% FCS-RPMI containing 0Á5 mg/ml collagenase (Wako, Osaka, Japan) and 10 lg/ml DNase I (Roche, Basel, Switzerland), and a single-cell suspension was obtained. For preparing splenic cells, spleens were mashed and were filtered with nylon mesh. From the obtained cells, CD4 + cells were separated using MACS system according to the manufacturer's instructions. For CFSE-labelling, the CD4 + cells were incubated in PBS containing CFSE for 6-7 min at room temperature, and then, the cells were washed twice.
Flow cytometry
Surface molecules on cells were stained with fluorescently labelled antibodies after Fc receptor block by anti-CD16/ 32 antibody. When biotinylated antibodies were used in the staining, secondary staining was performed using streptavidin-conjugated fluorescent reagents after the primary staining antibodies were washed out. In the case of dead cell-staining by propidium iodide, propidium iodide (2 lg/ml; Sigma) was added to samples after staining by antibodies and was washed out immediately. Intracellular Foxp3 was stained using Foxp3 staining buffer set (eBioscience) according to the manufacturer's instructions. Fluorescence levels were measured by FACS Verse (BD Bioscience) and data were analysed using FLOWJO software (Tree Star, Ashland, OR).
Cell culture
For Treg cell induction assay, MLN DC subsets from BALB/c mice (5 9 10 4 cells/ml) and splenic CD4 + cells from DO11.10 mice (5 9 10 5 cells/ml) were co-cultured in the presence of OVAp (10 nM). In some experiments, reagents, such as anti-PD-L1 antibody, anti-PD-L2 antibody, their isotype control antibodies, LE540, RA, DMSO and hTGF-b, were added. These cells and reagents were cultured in 200 lL of 10% FCS-RPMI in 96-well roundbottom plates for 3Á5 days in a 5% CO 2 humidified atmosphere at 37°.
For antigen uptake assay, MLN DC subsets from OVAfed or normal BALB/c mice (1 9 10 5 cells/ml) and CFSElabelled splenic CD4 + cells from DO11.10 mice (1 9 10 6 cells/ml) were co-cultured in the presence or absence of OVA protein (100 ng/ml) in 200 ll of 10% FCS-RPMI in 96-well flat-bottom plates for 3 days in a 5% CO 2 humidified atmosphere at 37°.
Quantitative PCR
Total RNA was extracted from cells using QIAShredder (QIAGEN, Hilden, Germany) and RNeasy mini kit (QIA-GEN) according to the manufacturer's instructions. From the total RNA, single-stranded cDNA was synthesized using Superscript II reverse transcriptase and Oligo dT primers (Invitrogen, Carlsbad, CA). Subsequently, realtime PCR was performed using Light Cycler (Roche) with SYBR Green PCR kit (QIAGEN) and subsequent primers -Hprt forward:
Relative gene expression was calculated as described previously except that target gene expression was normalized to Hprt gene expression as an internal control. 40 
Results
Mesenteric lymph node CD11c
+ cells contain four subsets expressing CD103 and/or PD-L1 CD11b + CD103 À PD-L1 Int subset highly expressed F4/80, which suggested that this subset contained macrophages. However, none of the subsets, including this CD11b
À PD-L1 Int subset, expressed a macrophage-specific marker, CD64, consistently with a previous study. 47 Hence, we concluded that these four CD11c + cell subsets are classified as DC subsets.
CD11b
À CD103 + PD-L1 High DC subset highly induces Treg cells Next, we compared Treg cell induction by the four MLN CD11c + cell subsets. The subsets were sorted and co-cultured with OVA-specific T cells in the presence of OVAp. To avoid blocking PD-L1 by anti-PD-L1 antibodies in the sorting process, the subsets were sorted using CD8a instead of PD-L1. Hence (Fig. 2a,b) .
Hence High subset, we examined the involvement of PD-L1 and PD-L2 by blocking these molecules using antibodies in the culture system. As a result, blocking of neither PD-L1 nor PD-L2 had any effect on the Treg cell induction by the subsets (Fig. 3a-d) . Further, simultaneous blocking of these molecules had no effect (Fig. 3e,f) . Hence, these molecules are not critical for Treg cell induction by the MLN DC subset, although it has been reported that PD-L1-or PD-L2-deficient MLN DCs cannot induce Treg cells. 38 This suggests that these molecules may be involved indirectly in Treg cell induction of MLN DCs.
Next, other factors involved in Treg cell induction by DCs were analysed. Treg cells are induced by TGF-b, and CD11b
Phenotypes of mesenteric lymph node CD11c + cells were analysed by flow cytometry. Representative plots are shown in Fig. 1 . this induction is synergistically enhanced by RA. [19] [20] [21] TGFb has been reported to be activated by DCs through an integrin a v b 8 -dependent mechanism. [26] [27] [28] [29] RA is produced by RALDH2 highly expressed in the intestinal CD103 + DCs. 19, 22, 23 In addition, IDO is also involved in Treg cell induction. 30 Therefore, expression of genes encoding TGF- The plot shows representative data from one experiment (n = 3). Symbols and horizontal bars indicate data from one well and mean of results from three wells, respectively. Statistical analysis was performed by two-way analysis of variance and subsequent Tukey's honest significant difference test. Values not sharing a common letter are significantly different (P < 0Á05). *P < 0Á05, ***P < 0Á001, n.s. (not significant): P ≥ 0Á1. (Fig. 5a,b) . This result suggests that RA is not critical for the Treg cell induction by the MLN DC subset. This was further confirmed using an antagonist of RA receptor, LE540. LE540 did not impair the Treg cell induction. In contrast to RA, exogenous TGF-b abrogated the difference in Treg cell induction among the subsets (Fig. 5c,d) . Therefore, TGF-b is a critical factor for Treg cell induction by the 
Retinoic acid regulates the intestine-homing receptors on Treg cells
Treg cells induced in MLNs should migrate into the intestine to suppress immune responses toward intestinal antigens and further to establish oral tolerance. 14, 15 The migration to the small intestine requires CCR9 and integrin a 4 b 7 expression induced by RA. 24 We compared expression of these homing-receptors on Treg cells induced by the MLN CD11c + cell subsets. As a result, the homing-receptors on Treg cells induced by the subsets were barely different (Fig. 6) . Both molecules were upregulated by exogenous RA and down-regulated by LE540. Hence, RA plays a critical role in the induction of CCR9 and a 4 b 7 on Treg cells. In addition, these results certified that RA and LE540 indeed had activity to affect T-cell responses, which confirms that RA is not critical for the Treg cell induction by CD11b À CD103 + PD-L1
High DCs in culture.
CD11b
À CD103 + PD-L1 High DCs are migratory subsets bearing orally administered antigens
Lymph nodes (LNs) contain DCs of two different origins.
One is a migratory DC, which migrates to the LNs from the periphery, and the other is resident DC, which is differentiated in the LNs from progenitors. Migration from the periphery is dependent on CCR7. [35] [36] [37] 48 Thus, we examined CCR7 expression of the four subsets. The Treg cell-inducing CD11b À CD103 + PD-L1 High DCs highly expressed Ccr7 gene and CCR7 on the cell surface (Fig. 7a,b left) . This DC subset exhibited a phenotype of migratory DCs, MHC II High (Fig. 7b right) 51·3   5·87  1·2 10·3  1·49  5·21  0·77  5·03  1·26   1·78  91·9  1·59  92·4  4·46  83·8  1·84  91·1   60·2  23·4  54·5  30·5  53·6  35·1  26·2   1·75  13·1  1·31  9·98  0·92  1·9  14·5 Values not sharing a common letter are significantly different (P < 0Á05). **P < 0Á01, ***P < 0Á001. phenotypes whereas the CD11b À CD103 + PD-L1 Low subset did not.
We examined whether the migratory DC subsets in MLNs are able to obtain and present orally administered antigens. The four MLN CD11c + cell subsets were purified from mice fed OVA in their drinking water and cocultured with CFSE-labelled OVA-specific T cells, and antigen presentation by the co-cultured CD11c + cell subsets was detected as a decrease in CFSE in the T cells, which indicates T-cell proliferation. The results showed that proliferation of the OVA-specific T cells was induced by the three MLN subsets that exhibited migratory phenotypes (Fig. 7c,d ). Among the three subsets, CD11b + CD103 + PD-L1 High and CD11b À CD103 + PD-L1
High subsets from mice fed control water induced little (< 0Á5%) T-cell proliferation (see Supplementary material, Fig. S1 ). Hence, at least, these two subsets may capture and carry orally administered antigens in vivo. In contrast, the CD11b + CD103 À PD-L1 Int subset induced relatively high antigen-independent proliferation (see Supplementary material, Fig. S1 ). The proliferated cells reached the same level as those induced by the subset from OVA-fed mice (Fig. 7c,d) . Hence, this subset might not present orally administered antigens, at least in this assay. CD11b
À CD103 + PD-L1 Low DCs barely induced T-cell proliferation (Fig. 7c,d ). On the other hand, the four subsets could capture and present OVA antigen supplemented in vitro (Fig. 7e,f) . Hence, the inability of CD11b À CD103 + PD-L1 Low DCs to present the orally administered antigens is indeed due to its location in vivo, i.e. this subset is a resident DC subset.
The in vitro Treg induction assays revealed that PD-L1 and PD-L2 are not involved in Treg induction (Fig. 3) , which is inconsistent with the previous study. 38 This suggests that these molecules may be involved indirectly in Treg cell induction in MLN DCs. One possible process was antigen uptake. Hence, we examined whether PD-L1 blocking can inhibit antigen uptake of the DC subsets in vitro. However, PD-L1 neutralization did not inhibit the antigen uptake of MLN DC subsets, but slightly increased T-cell proliferation (see Supplementary material, Fig. S2 ).
Collectively, CD11b À CD103 + PD-L1 High DCs capture antigens in the intestine, migrate to MLNs and highly induce Treg cells through TGF-b activation. For this reason, this subset may play an important role in induction of oral tolerance.
Discussion
In the intestine, immune responses to non-harmful antigens should be regulated. High . 37 Migratory DCs in MLNs are derived from both the small and large intestines. 49, 50 Both intestines are a source of MLN CD11b À CD103 + DCs whereas all CD11b + CD103 + DCs in MLNs originate in the small intestine. 50 In the large intestine, antigens in the distal colon are transported to caudal and iliac LNs, but not MLNs, and oral tolerance is induced at the sites. 51 Hence, the MLN CD11b À CD103 + PD-L1 High DCs might induce Treg cells specific to antigens derived from both the small intestine and the proximal colon. In addition to CD8a, XCR1 expression also differed between PD-L1 High and PD-L1 Low subsets in CD11b À CD103 + DCs. In the intestine, XCL1, the ligand of XCR1, might be secreted from T cells. 44 It is possible that XCR1 is down-regulated in the PD-L1
High subset in order to migrate toward CCR7 ligands secreted in MLNs. XCR1-expressing DCs in several tissues, including the intestine, function in antigen cross-presentation to CD8 + T cells. [19] [20] [21] In the present study, exogenous RA could induce and LE540 could inhibit expression of CCR9 and integrin a 4 b 7 on T cells, which means that the activities of both reagents were sufficient. One possible explanation is that RA-mediated Treg induction requires a proper dose of TGF-b. Indeed, some previous studies have reported that RA can enhance Treg cell induction only in the presence of exogenous TGF-b. 20, 21, 26, 53 Retinoic acid plays an important role in mucosal immunity. The present study revealed that MLN À CD103 + PD-L1 High DCs had the highest ALDH activity among the four subsets (Takano T. unpublished data). Therefore, this DC subset may be a large source of RA in MLNs. RA induces expression of gut-homing receptors on Treg cells. The homing of induced Treg cells to the intestine is indispensable for oral tolerance. 14, 15 Collectively, the present study suggests the possibility that MLN CD11b À CD103 + PD-L1 High DCs play a major role in such process inducing oral tolerance through Treg cells. The present study revealed that PD-L1 and PD-L2 on the DC subset were not critical for Treg cell induction, although a previous study reported that MLN DCs from PD-L1 À/À or PD-L2 À/À mice could not induce Treg cells. 38 PD-L1 was not involved in direct antigen uptake of the DCs, either. It is possible that PD-L1 and PD-L2 are involved in processes before the antigen presentation to T cells, such as antigen transfer from other cells that first capture antigens in vivo, DC activation, and DC migration to MLNs. Consistently, it has been reported that migratory DCs highly express the gene encoding PD-L1, which raises a possibility that this molecule is involved in migration. 55 In addition, there are differences between the previous 38 and the present studies in the culture conditions used, so it is also possible that PD-L1 is required for Treg cell induction in a specific condition, e.g. a specific cytokine milieu or antigen concentration. Oral tolerance, systemic immune hyporesponsiveness to orally administered antigens, is induced partly by oral antigen-specific Treg cell induction in the intestinal immune system. 2, 3 An intentional induction of oral tolerance could be a therapeutic strategy for allergy and autoimmune diseases. Therefore, the MLN CD11b À
CD103
+ PD-L1 High DC subset may be a potential target for such therapeutic strategy.
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